Published
Andrea Necchi, MD, San Raffaele Hospital and Scientific Institute, and Karine Tawagi, MD, University of Illinois, break down in detail the first results of SURE-02, which was a phase II study of neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by response-adapted bladder sparing and adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer.
- Category
- Oncology
Be the first to comment
Up Next
-
08:50
The SunRISe Trials and TAR-200: Bladder-Sparing Therapies for NMIBC
-
09:28
Advancing Neoadjuvant Therapies: Oncolytic Immunotherapy and Nivolumab in MIBC
-
04:34
IMbrave050 Trial Design: Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma
-
18:17
Case Discussion | Overactive Bladder | Non-Compliant Bladder | CT Diagnosis - Urethrovaginal Fistula
-
08:42
RETAIN-2: Risk-Enabled Therapy After Neoadjuvant Chemo-Immunotherapy for MIBC
-
16:17
I Couldn’t Stop Peeing! Frequent Urination to Bladder Cancer | Bladder Cancer | The Patient Story
-
05:01
Controversy Over Adjuvant CDK4/6 Inhibitors in HER2-Negative Breast Cancer
-
08:22
Bladder-Sparing with Systemic Therapy: Insights from RETAIN-2 and Future Directions
-
07:14
Redefining Urothelial Cancer Care: EV-Pembro, De-Escalation, and Future Strategies
-
06:41
Primary Care and SCI - Bladder: 2. Screening and Diagnosis of Bladder Complications
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
